Avelumab for People With Recurrent Respiratory Papillomatosis
Conditions: Recurrent Respiratory Papillomatosis; Juvenile Laryngeal Papilloma; Laryngeal Papilloma, Recurrent; Respiratory Papillomatosis; Human Papilloma Virus Intervention: Drug: Avelumab Sponsor: National Cancer Institute (NCI) Recruiting - verified August 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials